OncoMatch/Clinical Trials/NCT07856732
Using Silverlon® for Head and Neck Patients With Tracheostomies
Official title: Feasibility and Tolerability of Silverlon® for Definitive Head and Neck Patients With Tracheostomies
Is NCT07856732 recruiting? Yes, currently enrolling (Oct 2026). This Phase 1 trial studies Silverlon® for head and neck cancer.
Treatment: Silverlon® — The purpose of this study is to determine if prophylactic silver-nylon burn dressing Silverlon® prevents a severe skin reaction under tracheostomy collars. It also aims to establish whether patients can tolerate Silverlon® under their tracheostomy with daily removal and weekly changes.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Head and Neck Squamous Cell Carcinoma
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Upstate Medical University · Syracuse, New York
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07856732 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages